Creative Biolabs Strengthens Liposome and Lipid-Based Drug Delivery Development Solutions with Integrated PK/PD Support

Creative Biolabs provides customized support across key stages of lipid-based therapeutic development, helping researchers optimize delivery systems for different types of therapeutic payloads, ...

Generative Biology Is Rewriting The Rules Of Drug Discovery

Generative biology is moving from code to the clinic, promising faster drug discovery while raising hard questions about ...

Can-Fite Highlights Advanced FDA and EMA Regulatory Status of its Phase III Drug Candidates

Namodenoson Holds FDA Fast Track and U.S. and European Orphan Drug Designations; Piclidenoson and Namodenoson Are Advancing in Phase III Programs Ramat Gan, Israel, Aug. 12, 2026 (GLOBE NEWSWIRE) -- ...

ArkBio's RSV Antiviral Drug Ziresovir Receives FDA Approval for Phase II Clinical Trial

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the U.S. Food and Drug Administration (FDA) has ...
India Education Diary on MSN

Vivekanand Education Society's College of Pharmacy hosts international workshop on 'Regulatory milestones in drug development'

12th August 2026, Aug. 12 -- focused organisation; H.A.B.I.T. Foundation, an initiative promoting entrepreneurship, innovation and industry-academia collaboration; and AIPFC (Association IP ...

Immunic advances MS drug toward key Phase 3 data, expects results by year-end

Immunic Inc (NASDAQ:IMUX, FRA:10VA) is preparing for a series of clinical and corporate milestones as it advances its lead ...
GlobalData on MSN

Sobi licenses Innate’s CTCL drug for up to $580m as it heads to Phase III

Innate is planning to begin a Phase III confirmatory trial on lacutamab as it vies for the drug’s accelerated approval in a rare subset of CTCL.

Amgen Lifts Outlook on Strong Drug Sales, to End Early Development of Obesity Treatment

The biotechnology company now expects full-year revenue between $38.2 billion and $39.4 billion, but said it was halting the ...

JW Pharmaceutical Proves Efficacy of Key 6mg Dose of Gout Treatment ‘Epaminurad’ in Multinational Phase 3 Trial

JW Pharmaceutical (KRX:001060) announced that the multinational Phase 3 clinical trial of its gout treatment candidate ...

Can-Fite BioPharma Ltd.: Can-Fite Highlights Advanced FDA and EMA Regulatory Status of its Phase III Drug Candidates

Namodenoson Holds FDA Fast Track and U.S. and European Orphan Drug Designations; Piclidenoson and Namodenoson Are Advancing in Phase III Programs Ramat Gan, Israel, Aug. 12, 2026 (GLOBE NEWSWIRE) -- ...

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS into Phase 2

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum ...

InduPro raises $77M, begins first human trial of cancer drug

Seattle biotech InduPro has raised $77 million and dosed its first patient in a Phase 1 trial of an experimental cancer drug, ...